BRAF and melanoma: Recently, the introduction of molecularly targeted therapies and immunotherapy has given hope to patients with advanced melanoma [9, 10], and several trials are evaluating the effect of BRAF inhibitors and immune checkpoint inhibitors in patients with brain metastases [1, 11].